August 25, 2026
A new tariff threat aimed at China may sound tough from a podium. At the checkout line, it risks becoming another bill passed to families, workers and small businesses.
AP News reported on August 25, 2026, that President Trump moved toward a new tariff on Chinese goods, framing the penalty around fentanyl and trade enforcement. The politics are easy to understand. A tariff sounds forceful, simple and patriotic. The economics are less convenient. Another China tariff is still a price hike unless the administration can prove it will do more than shift costs onto households, workers and small businesses.
Fentanyl is a real crisis. Families have lost children, siblings, parents and neighbors. Communities need serious action against trafficking networks, precursor chemicals, money laundering and online distribution. But a tariff is a blunt economic tool, not a public-health strategy. If the goal is to save lives, the country needs treatment access, harm reduction, border and port enforcement, financial investigations, international cooperation and accountable policing of criminal supply chains. Raising import costs is not a substitute for that work.
The consumer risk is direct. Tariffs are paid by importers and usually move through supply chains until someone absorbs them. Large companies may pass costs to customers. Smaller firms may eat margin they cannot afford. Workers can face slower hiring, fewer hours or layoffs if orders fall. Families already managing groceries, rent, childcare and debt do not experience tariff policy as a slogan. They experience it as another pressure point in a budget that is already too tight.
Republicans will say China pays. That claim has always been politically useful and economically weak. In practice, American consumers and businesses often carry a large share of the burden. Even when tariffs create leverage, they need a defined objective, a credible off-ramp and a plan for the domestic industries caught in the middle. Without that discipline, trade policy becomes theater with invoices attached.
Democrats should not respond by sounding indifferent to China policy. There are legitimate concerns about forced labor, industrial overcapacity, intellectual property, supply-chain dependence, national security and Beijing's role in global manufacturing. A progressive trade policy can be tough. But tough should mean strategic, worker-centered and evidence-based. It should not mean using every problem as an excuse for a new tax on imported goods.
The smarter path starts with targeting. If specific companies or networks are tied to fentanyl precursors, sanction them. If ports need technology and staffing, fund them. If customs enforcement is underpowered, modernize it. If pharmaceutical and chemical supply chains are vulnerable, build domestic capacity with labor standards. Broad tariffs often punish everyone while letting the worst actors adapt.
There is also an inflation problem. The administration cannot claim victory over prices while casually adding costs to common goods. Retail shelves are connected to warehouses, shipping contracts, financing, insurance and wages. A tariff ripples through that system. When officials dismiss the impact, they are usually counting on families to absorb what policymakers prefer not to explain.
Workers deserve more than symbolic protection. Trade policy should raise standards at home and abroad, not simply move pain around. That means enforceable labor provisions, anti-monopoly policy, domestic manufacturing investment, clean-energy supply-chain planning, apprenticeship pipelines and procurement rules that reward decent jobs. Tariffs can sometimes be part of a toolkit. They cannot be the whole toolbox.
Small businesses are another weak point in the Trump approach. A giant retailer can renegotiate suppliers, diversify sourcing or pressure manufacturers. A local importer, repair shop, restaurant supplier or online seller may not have those options. If costs rise suddenly, the choice can be ugly: raise prices, cut workers, reduce inventory or close. That is not economic strength.
The politics of fentanyl also require honesty. Families harmed by addiction should not be used as cover for poorly designed trade policy. The public deserves to know how the tariff will reduce supply, how success will be measured, what costs are expected and who will be protected if prices rise. If the administration cannot answer those questions, the policy is not ready.
Another China tariff is still a price hike because costs do not disappear when politicians rename them toughness. America needs serious fentanyl enforcement and a serious industrial strategy. It needs trade rules that protect workers, consumers and human rights. What it does not need is another broad penalty that lets Washington claim strength while families discover the bill at the register.